Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The Department of Attorney General of Hawaii announced that Bristol-Myers Squibb (NYSE:BMY) and three units of Sanofi (NASDAQ ...

Hawaii's attorney general's office says pharmaceutical companies have agreed to pay the state $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix ...

Bristol-Myers Squibb will pay $350 million to settle Hawaii's lawsuit over Plavix marketing practices, ending claims without ...

HPR's Ashley Mizuo reports on the settlement with pharmaceutical companies in the lawsuit over a blood thinner.

The settlement concludes a 12-year legal battle over the efficacy of Plavix for Asian, Pacific Islander and Native Hawaiian ...

and three units of Sanofi (NASDAQ:SNY) have agreed to pay $700M to the state to resolve nearly 12 years of litigation related to the companies’ marketing of blood thinner Plavix. The lawsuit ...

Pharmaceutical giants Bristol Myers Squibb and Sanofi have agreed to pay $700 million to Hawaii to settle a lawsuit over the ...

“Plavix has helped millions of people with cardiovascular ... The settlement divides the $700 million equally between Bristol Myers Squibb and Sanofi, with the funds to be paid by wire transfer ...